Glioma difuso de línea media H3K27M positivo en adulto. Caso clínico
^aThe 2016 WHO Classification of Tumours of the Central Nervous System incorporates a new diagnostic entity: the mutant diffuse midline glioma H3K27, a tumor with a characteristic location and special molecular biology. We report the case of a 51-year-old male patient with progressive diplopia. The...
Guardado en:
Autores principales: | ARANEDA,PATRICIA, SUJIMA,EMI, PAREDES-MANZO,PATRICIO, VALLEJO,RODRIGO, VALDIVIA,FELIPE, SINNING,MARIANA, GALLEGOS,MARCELA, FULLER,GREGORY |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2019
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019001101487 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Machine learning modeling of genome-wide copy number alteration signatures reliably predicts IDH mutational status in adult diffuse glioma
por: Nicholas Nuechterlein, et al.
Publicado: (2021) -
PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review
por: Fana M, et al.
Publicado: (2020) -
Glioma nasal gigante: reporte de un caso
por: Medel B,Simón, et al.
Publicado: (2015) -
New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma
por: Davis P. Argersinger, et al.
Publicado: (2021) -
Angiogenic potential of the cerebrospinal fluid (CSF) of patients with high-grade gliomas measured with the chick embryo chorioallantoic membrane assay (CAM)
por: Sinning,Mariana, et al.
Publicado: (2012)